Synthesis, characterization, and antimicrobial activity of silver carbene complexes derived from 4,5,6,7-tetrachlorobenzimidazole against antibiotic resistant bacteria.

Center for Silver Therapeutics Research, Department of Chemistry, The University of Akron, Akron, OH 44325-3601, USA.
Dalton Transactions (Impact Factor: 3.81). 03/2012; 41(21):6500-6. DOI: 10.1039/c2dt00055e
Source: PubMed

ABSTRACT Silver N-heterocyclic carbene complexes have been shown to have great potential as antimicrobial agents, affecting a wide spectrum of both Gram-positive and Gram-negative bacteria. A new series of three silver carbene complexes (SCCs) based on 4,5,6,7-tetrachlorobenzimidazole has been synthesized, characterized, and tested against a panel of clinical strains of bacteria. The imidazolium salts and their precursors were characterized by elemental analysis, mass spectrometry, (1)H and (13)C NMR spectroscopy, and single crystal X-ray diffraction. The silver carbene complexes, SCC32, SCC33, and SCC34 were characterized by elemental analysis, (1)H and (13)C NMR spectroscopy, and single crystal X-ray diffraction. These complexes proved highly efficacious with minimum inhibitory concentrations (MICs) ranging from 0.25 to 6 μg mL(-1). Overall, the complexes were effective against highly resistant bacteria strains, such as methicillin-resistant Staphylococcus aureus (MRSA), weaponizable bacteria, such as Yersinia pestis, and pathogens found within the lungs of cystic fibrosis patients, such as Pseudomonas aeruginosa, Alcaligenes xylosoxidans, and Burkholderia gladioli. SCC33 and SCC34 also showed clinically relevant activity against a silver-resistant strain of Escherichia coli based on MIC testing.

  • [Show abstract] [Hide abstract]
    ABSTRACT: The discovery of cisplatin's antitumor activity in 1969 prompted the search for novel metal-containing complexes as potential anticancer drugs. Among these novel complexes, metal N-heterocyclic carbene (NHC) complexes have recently gained considerable attention because they perfectly fit prerequisites for efficient drug design and fast optimization. Moreover, most of them have shown higher cytotoxicity than cisplatin. This review describes the advances that have been achieved in using transition metal (Ag, Au, Pt, Pd, Cu, Ni, and Ru) complexes containing NHC ligands as antitumor agents. Their modes of action at the cellular lever are further discussed. All these initial achievements clearly demonstrate the great potential of metal-NHC complexes as antitumor agents.
    Chemical Society Reviews 11/2012; · 24.89 Impact Factor
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: Two silver(I) complexes-{[Ag(4-pmOpe)]NO3 }n and [Ag(2-bimOpe)2 ]NO3 -and three copper(II) complexes-[Cu4 Cl6 O(2-bimOpe)4 ], [CuCl2 (4-pmOpe)2 ], and [CuCl2 (2-bis(pm)Ope]-were synthesized by reaction of silver(I) nitrate or copper(II) chloride with phosphate derivatives of pyridine and benzimidazole, namely diethyl (pyridin-4-ylmethyl)phosphate (4-pmOpe), 1H-benzimidazol-2-ylmethyl diethyl phosphate (2-bimOpe), and ethyl bis(pyridin-2-ylmethyl)phosphate (2-bis(pm)Ope). These compounds were characterized by (1) H, (13) C, and (31) P NMR as well as IR spectroscopy, elemental analysis, and ESIMS spectrometry. Additionally, molecular and crystal structures of {[Ag(4-pmOpe)]NO3 }n and [Cu4 Cl6 O(2-bimOpe)4 ] were determined by single-crystal X-ray diffraction analysis. The antimicrobial profiles of synthesized complexes and free ligands against test organisms from the ATCC and clinical sources were determined. Silver(I) complexes showed good antimicrobial activities against Candida albicans strains (MIC values of ∼19 μM). [Ag(2-bimOpe)2 ]NO3 was particularly active against Pseudomonas aeruginosa and methicillin-resistant Staphylococcus epidermidis, with MIC values of ∼5 and ∼10 μM, respectively. Neither copper(II) complexes nor the free ligands inhibited the growth of test organisms at concentrations below 500 μg mL(-1) .
    ChemMedChem 11/2013; · 2.84 Impact Factor
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: The new alcohol- and ether-functionalised-NHC silver(i) complexes bis(1-(2,6-diisopropylphenyl)-3-(2-hydroxyethyl)-1H-imidazol-2(3H)-ylidene)silver(i) chloride, [Ag{ImDiPP(C2OH)}2]Cl (), bis(1-(2-hydroxyethyl)-3-mesityl-1H-imidazol-2(3H)-ylidene)silver(i) chloride, [Ag{ImMes(C2OH)}2]Cl (), bis(1-(2-hydroxyethyl)-3-methyl-1H-imidazol-2(3H)-ylidene)silver(i) chloride, [Ag{ImMe(C2OH)}2]Cl (), bis(1-(2,6-diisopropylphenyl)-3-(2-hydroxyethyl)-1H-imidazol-2(3H)-ylidene)silver(i) tetrafluoroborate, [Ag{ImDiPP(C2OH)}2]BF4 (), and bis(1-(2,6-diisopropylphenyl)-3-(2-methoxyethyl)-1H-imidazol-2(3H)-ylidene)silver(i) chloride, [Ag{ImDiPP(C2OMe)}2]Cl (), were synthesized and fully characterized by NMR spectroscopy and single crystal X-ray diffraction. For some complexes, an uncommon heteronuclear coupling (4)J((107/109)Ag-H) was unveiled. Their ability to transfer the NHC ligand to Ni(ii) was assessed in the presence of different nickel(ii) sources; the bis-NHC Ni(ii) complex bis(1-(2,6-diisopropylphenyl)-3-(2-methoxyethyl)-1H-imidazol-2(3H)-ylidene)nickel(ii) chloride, [NiCl2{ImDiPP(C2OMe)}2] (), was obtained from and shown by X-ray diffraction study to have a trans-arrangement of the two NHC ligands. However, in contrast to other Ag(i) NHC complexes the transmetallation reaction failed with the hydroxyl-functionalised silver complexes, possibly due to the acidity of the alcohol OH function, leading overall to reprotonation of the CNHC and isolation of the corresponding imidazolium salts.
    Dalton Transactions 01/2014; · 3.81 Impact Factor